» Articles » PMID: 19004958

Mice Lacking the ISG15 E1 Enzyme UbE1L Demonstrate Increased Susceptibility to Both Mouse-adapted and Non-mouse-adapted Influenza B Virus Infection

Overview
Journal J Virol
Date 2008 Nov 14
PMID 19004958
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

ISG15 functions as a critical antiviral molecule against influenza virus, with infection inducing both the conjugation of ISG15 to target proteins and production of free ISG15. Here, we report that mice lacking the ISG15 E1 enzyme UbE1L fail to form ISG15 conjugates. Both UbE1L(-/-) and ISG15(-/-) mice display increased susceptibility to influenza B virus infection, including non-mouse-adapted strains. Finally, we demonstrate that ISG15 controls influenza B virus infection through its action within radioresistant stromal cells and not bone marrow-derived cells. Thus, the conjugation of ISG15 to target proteins within stromal cells is critical to its activity against influenza virus.

Citing Articles

Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PL).

Taylor A, Amporndanai K, Rietz T, Zhao B, Thiruvaipati A, Wei Q ACS Med Chem Lett. 2024; 15(8):1351-1357.

PMID: 39140055 PMC: 11318101. DOI: 10.1021/acsmedchemlett.4c00238.


The ISG15-Protease USP18 Is a Pleiotropic Enhancer of HIV-1 Replication.

Lin C, Kuffour E, Li T, Gertzen C, Kaiser J, Luedde T Viruses. 2024; 16(4).

PMID: 38675828 PMC: 11053637. DOI: 10.3390/v16040485.


Type I interferon regulation by USP18 is a key vulnerability in cancer.

Jove V, Wheeler H, Lee C, Healy D, Levine K, Ralph E iScience. 2024; 27(4):109593.

PMID: 38632987 PMC: 11022047. DOI: 10.1016/j.isci.2024.109593.


ISG15: its roles in SARS-CoV-2 and other viral infections.

Sarkar L, Liu G, Gack M Trends Microbiol. 2023; 31(12):1262-1275.

PMID: 37573184 PMC: 10840963. DOI: 10.1016/j.tim.2023.07.006.


The diverse repertoire of ISG15: more intricate than initially thought.

Kang J, Kim Y, Jeon Y Exp Mol Med. 2022; 54(11):1779-1792.

PMID: 36319753 PMC: 9722776. DOI: 10.1038/s12276-022-00872-3.


References
1.
DCunha J, Ramanujam S, WAGNER R, Witt P, KNIGHT Jr E, Borden E . In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol. 1996; 157(9):4100-8. View

2.
Shornick L, Wells A, Zhang Y, Patel A, Huang G, Takami K . Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J Immunol. 2008; 180(5):3319-28. DOI: 10.4049/jimmunol.180.5.3319. View

3.
Zhao C, Denison C, Huibregtse J, Gygi S, Krug R . Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A. 2005; 102(29):10200-5. PMC: 1177427. DOI: 10.1073/pnas.0504754102. View

4.
Okumura F, Zou W, Zhang D . ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev. 2007; 21(3):255-60. PMC: 1785121. DOI: 10.1101/gad.1521607. View

5.
Okumura A, Lu G, Pitha-Rowe I, Pitha P . Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A. 2006; 103(5):1440-5. PMC: 1360585. DOI: 10.1073/pnas.0510518103. View